Stay updated on Daratumumab for Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.

Latest updates to the Daratumumab for Multiple Myeloma Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoChange DetectedThe study status was updated to Completed and the record now includes the Study Protocol and Statistical Analysis Plan (Revision: v3.4.1).SummaryDifference0.9%

- Check18 days agoChange DetectedThese are minor UI/text updates: adding 'Show glossary', capitalization tweaks for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updating the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check26 days agoChange DetectedAdded a standalone 'Last Update Posted' label and removed the 'Last Update Posted (Estimated)' label, affecting only timestamp display. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Florida as a location in the Locations section and updated the page revision to v3.3.3; the older Florida Locations label and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

Stay in the know with updates to Daratumumab for Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab for Multiple Myeloma Clinical Trial page.